Fuji mulls Given Imaging buying for up to $750M

| | Health Imaging | Enterprise Imaging

Fujifilm Holdings is a chief suitor for Given Imaging, according to Israeli publication Calcalist.

On Oct. 17, Yoqneam, Israel-based Given Imaging announced it was evaluating a range of strategic options, including preliminary non-binding indications of interest received from a number of parties relating to a possible merger or sale.

Given Imaging stressed its intent to actively explore these and other alternatives, including a strategic alliance or additional acquisitions such as its recent acquisition of the assets of the Smart Pill. 

On Oct. 21, the Calcalist reported that Fujifilm is the key negotiator for the acquisition with a price that reflects a $750 million market cap for Given Imaging.

Given Imaging’s board of directors has appointed an executive committee consisting of the chairman and two independent directors to oversee the process. The investment banking firm Barclays is assisting the company in the process.

Related Content

Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
Residents' structured reports get boost from software assistance
Do large language models help or hinder workflows related to radiology reports?
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.